Chugai files in Japan for Hemlibra for hemophilia A without inhibitors and to extend dosing interval April 27, 2018
FDA grants breakthrough therapy designation to OMS-721 for HSCT thrombotic microangiopathy April 27, 2018
Sirolimus granted FDA orphan drug designation for the treatment of sickle cell disease April 24, 2018
FDA expands approval of Vonvendi to include perioperative management of bleeding in adults with VWD April 18, 2018
FDA grants breakthrough therapy designation to Hemlibra for hemophilia A without inhibitors April 17, 2018
RSS